跳至主要内容
临床试验/EUCTR2016-004298-41-ES
EUCTR2016-004298-41-ES进行中(未招募)1 期

Intrabdominal hyperthermic chemotherapy using gemcitabine to treat pancreatic carcinomatosis - Intrabdominal hyperthermic chemotherapy to treat pancreatic carcinomatosis

Hospital General Ciudad Real0 个研究点目标入组 42 人开始时间: 2017年3月31日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Surgically resectable pancreatic adenocarcinoma
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 21
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 21

排除标准

  • · Voluntary refusal to participate in the trial
  • · Existence of distant or locoregional disease that contraindicates surgical treatment, diagnosed preoperatively or in the intraoperative act
  • · Existence of synchronous neoplastic disease
  • · Exclusion after perioperative anesthetic study

研究者

发起方
Hospital General Ciudad Real

相似试验